Genprex, Inc. - stock earnings
GNPX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -7.7 million USD | ? USD |
| 2023Q2 | -8.0 million USD | ? USD |
| 2023Q1 | -9.1 million USD | ? USD |
| 2022Q4 | -6.4 million USD | ? USD |
| 2022Q3 | -6.1 million USD | ? USD |
| 2022Q2 | -5.2 million USD | ? USD |
| 2022Q1 | -5.7 million USD | ? USD |
| 2021Q4 | -5.7 million USD | ? USD |
| 2021Q3 | -3.4 million USD | ? USD |
| 2021Q2 | -4.0 million USD | ? USD |
| 2021Q1 | -6.5 million USD | ? USD |
| 2020Q4 | -5.2 million USD | ? USD |
| 2020Q3 | -2.8 million USD | ? USD |
| 2020Q2 | -4.4 million USD | ? USD |
| 2020Q1 | -5.6 million USD | ? USD |
| 2019Q4 | -2.4 million USD | ? USD |
| 2019Q3 | -2.4 million USD | ? USD |
| 2019Q2 | -3.7 million USD | ? USD |
| 2019Q1 | -3.4 million USD | ? USD |
| 2018Q4 | -3.4 million USD | ? USD |
| 2018Q3 | -2.2 million USD | ? USD |
| 2018Q2 | -6.1 million USD | ? USD |
| 2018Q1 | -666581 USD | ? USD |
| 2017Q4 | -715098 USD | ? USD |
| 2017Q3 | -715098 USD | ? USD |
| 2017Q2 | -1.2 million USD | ? USD |
| 2017Q1 | -751303 USD | ? USD |
| 2016Q4 | -999067 USD | ? USD |
| 2016Q3 | -719853 USD | ? USD |
| 2016Q2 | -2.1 million USD | ? USD |
| 2016Q1 | -323478 USD | ? USD |
| 2015Q4 | -1.1 million USD | ? USD |
GNPX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -31.5 million USD | ? USD |
| 2022 | -29.5 million USD | ? USD |
| 2021 | -19.6 million USD | ? USD |
| 2020 | -17.9 million USD | ? USD |
| 2019 | -10.7 million USD | ? USD |
| 2018 | -12.4 million USD | ? USD |
| 2017 | -3.3 million USD | ? USD |
| 2016 | -4.1 million USD | ? USD |
| 2015 | -1.1 million USD | ? USD |
GNPX
Price: $2.61
52 week price:
Earnings Per Share: -22.56 USD
P/E Ratio: -0.18
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 159356
Market Capitalization: 5.1 million